We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Tool Improves PET Imaging Capabilities

By MedImaging International staff writers
Posted on 21 Jun 2021
Print article
Image: Equivalent diagnostic image quality of SubtlePET software (Photo courtesy of Subtle Medical)
Image: Equivalent diagnostic image quality of SubtlePET software (Photo courtesy of Subtle Medical)
Novel image enhancement technology improves positron emission tomography (PET) radiotracer performance.

The Subtle Medical (Menlo Park, CA, USA) SubtlePET 2.0 is a ready-to-deploy artificial intelligence (AI) algorithm designed to improve PET imaging efficiency and patient care during scans with 18F-FDG, 18F-Amyloid, 18F-Fluciclovine, 18F-DOPA, 18F-Choline, 18F-DCFPyL, Ga-68 Dotatate, and Ga-68 PSMA radiotracers. The image enhancement software applies denoising, based on deep learning (DL) algorithms that improve image quality during the acquisition phase of low count PET scans, enabling providers to expedite patient care and improve comfort during PET exams.

The technology enhances PET images without any interruption or alteration to the imaging workflow. A significant improvement in image quality of noisy images resulting from shorter scans (up to 25% of the original scan time) is provided, which is particularly beneficial for children and those undergoing repeat PET exams. The vendor-neutral software integrates seamlessly with any scanner and picture archiving and communication systems (PACS) system, boosting exam throughput via accelerated protocols and image quality.

“We are dedicated to pushing the boundaries of new AI based products as well as continuously improving our existing product line with new features and capabilities. These continuous advancements will provide patients a significantly better patient experience,” said Josh Gurewitz, chief commercial officer of Subtle Medical. “Our products directly support our mission to improve access to faster, safer, and smarter diagnostic imaging.”

“By adding SubtlePET to our AI toolkit, we are dramatically increasing the efficiency of our nuclear medicine program and directly impacting the patient experience. We can scan a patient four times faster than normal, yet maintain excellent diagnostic image quality with SubtlePET, not otherwise impacting workflow,” said Ravi Jain, MD, PhD, of Middlesex Health (Middletown, CT, USA). “Subtle's technology helps support our commitment to patient care.”

PET is a nuclear medicine imaging technique that produces a 3D image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide tracer. Tracer concentrations within the body are then constructed in 3D by computer analysis. In modern PET-CT scanners, 3D imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.

Related Links:
Subtle Medical

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Wireless Handheld Ultrasound System
TE Air
Ultrasound Needle Guide
Ultra-Pro II
New
Color Doppler Ultrasound System
KC20

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.